Boubaker, A., Poetschger, U., Lambert, B., Castellani, M. R., Bar-Sever, Z., Oudoux, A., … Ladenstein, R. L. (2014). Validation of the MIBG SIOPEN scoring method in two independent high-risk neuroblastoma trials. In Journal of Clinical Oncology (Vol. 32, pp. 10029–10029). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.10029

Boubaker, Ariane, Ulrike Poetschger, Bieke Lambert, Maria Rita Castellani, Zvi Bar-Sever, Aurore Oudoux, Anna Kaminska, et al. “Validation of the MIBG SIOPEN scoring method in two independent high-risk neuroblastoma trials.” In Journal of Clinical Oncology, 32:10029–10029. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.10029.

Boubaker A, Poetschger U, Lambert B, Castellani MR, Bar-Sever Z, Oudoux A, et al. Validation of the MIBG SIOPEN scoring method in two independent high-risk neuroblastoma trials. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 10029–10029.

Boubaker, Ariane, et al. “Validation of the MIBG SIOPEN scoring method in two independent high-risk neuroblastoma trials.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 10029–10029. Crossref, doi:10.1200/jco.2014.32.15_suppl.10029.

Boubaker A, Poetschger U, Lambert B, Castellani MR, Bar-Sever Z, Oudoux A, Kaminska A, Taborska K, Biassoni L, Kreissman SG, Yanik GA, Naranjo A, Parisi MT, Shulkin BL, Matthay KK, Park JR, Valteau-Couanet D, Ladenstein RL. Validation of the MIBG SIOPEN scoring method in two independent high-risk neuroblastoma trials. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 10029–10029.